English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Ruth de Jauregui | May 30, 2017

AstraZeneca announces top-line results in EXSCEL Phase IIIb/IV trial of Bydureon in diabetes patients

John Breslin | May 30, 2017

Collapse of health insurance merger to benefit consumers, U.S. prosecutor says

Robert Hadley | May 29, 2017

Amgen says Repatha an improvement over standard statin treatment

Robert Hadley | May 29, 2017

Dermabond Prineo Skin Closure System can save money, cut infection risks, Johnson & Johnson says

Robert Hadley | May 29, 2017

Restricted diet may trigger cravings, NIH study says

Charmaine Little | May 29, 2017

NHLBI program raises awareness of COPD

Robert Hadley | May 28, 2017

NIH study sheds new light on retinal disorders

Robert Hadley | May 28, 2017

Bronchodilators equal corticosteroids for COPD use, Novartis study claims 

Trending

+ Pharmaceuticals
Patient Daily | Oct 23, 2025

Empower seeks dismissal of Eli Lilly suit in Texas federal court

Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues

+ Pharmaceuticals
Patient Daily | Oct 29, 2025

Paragon Health Institute senior fellow: 340B program 'needs real reform'

Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'

  • « First
  • «
  • …
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily